Financhill
Sell
28

TCRT Quote, Financials, Valuation and Earnings

Last price:
$2.00
Seasonality move :
26.55%
Day range:
$1.95 - $2.04
52-week range:
$1.63 - $32.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.19x
Volume:
9.6K
Avg. volume:
30.1K
1-year change:
-74.23%
Market cap:
$3.2M
Revenue:
$5K
EPS (TTM):
-$7.41

Earnings Data

Next earnings date for TCRT
May 09
2025
Most recent earnings per share
-$0.70
Missed by $0.70
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TCRT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/14/2024 Q3 -- -- -$0.70 -- --
08/14/2024 Q2 -- $4K -$0.71 -- --
05/10/2024 Q1 -- $1K -$1.10 -- --
03/27/2024 Q4 -- $1K -$4.90 -$4.50 -$0.40
11/14/2023 Q3 -- -- -$6.00 -$5.25 -$0.75
08/14/2023 Q2 -- -- -$5.49 -$6.75 $1.26
05/10/2023 Q1 -- -- -$6.30 -$6.60 $0.30
03/07/2023 Q4 -- -- -$6.00 -$10.00 $4.00
11/14/2022 Q3 -- -- -$6.00 -$10.75 $4.75
08/15/2022 Q2 -- -- -$7.50 -$10.25 $2.75
05/16/2022 Q1 -- -- -$7.50 -$9.90 $2.40
03/30/2022 Q4 -- -- -$7.50 -$12.64 $5.14
11/08/2021 Q3 -- -- -$16.50 -- --
06/30/2021 Q2 -- -- -$16.50 -- --
03/31/2021 Q1 -- -- -$15.00 -- --
12/31/2020 Q4 -- -- -$16.50 -- --
09/30/2020 Q3 -- -- -$15.00 -- --
06/30/2020 Q2 -- -- -$13.50 -- --
03/31/2020 Q1 -- -- -$13.50 -- --
12/31/2019 Q4 -- -- -$13.50 -- --
09/30/2019 Q3 -- -- -$64.50 -- --
06/30/2019 Q2 -- -- -$13.50 -- --
03/31/2019 Q1 -- -- -$12.00 -- --
12/31/2018 Q4 -- -- $193.50 -- --
09/30/2018 Q3 -- -- -$19.50 -- --
06/30/2018 Q2 -- -- -$18.00 -- --
03/31/2018 Q1 -- -- -$22.50 -- --
12/31/2017 Q4 -- -- -$19.50 -- --
09/30/2017 Q3 -- -- -$19.50 -- --
06/30/2017 Q2 -- -- -$19.50 -- --
03/31/2017 Q1 -- -- -$22.50 -- --
12/31/2016 Q4 -- -- -$16.50 -- --
09/30/2016 Q3 -- -- -$16.50 -- --
06/30/2016 Q2 -- -- -$151.50 -- --
03/31/2016 Q1 -- -- -$13.50 -- --
12/31/2015 Q4 -- -- -$10.50 -- --
09/30/2015 Q3 -- -- -$21.00 -- --
06/30/2015 Q2 -- -- -$16.50 -- --
03/31/2015 Q1 -- -- -$103.50 -- --
12/31/2014 Q4 -- -- -$13.50 -- --

Alaunos Therapeutics Earnings Questions

  • How Much did Alaunos Therapeutics Generate in Revenue Last Quarter?

    Alaunos Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Alaunos Therapeutics Beat Earnings Last Quarter?

    Alaunos Therapeutics announced earnings per share of -$0.70 which represents a miss of analyst forecast a -- per share.

  • Is Alaunos Therapeutics Profitable?

    Alaunos Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Alaunos Therapeutics EPS Next Year?

    Alaunos Therapeutics's earnings are forecast to decrease from -$330.00 per share to -$22.50 per share next year representing a decrease of -98.18%.

  • When is Alaunos Therapeutics's Earnings Date?

    Alaunos Therapeutics's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock